Rare diseases
Investigational molecules
Locations
Back to Belgium1 clinical trial in Herent, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical research focusing on SARS-CoV-2 immunity in diverse population groups, investigating antibody responses and immune system functionality in both healthy individuals and immunocompromised patients.
This longitudinal study examines immune responses in nursing home residents, dialysis patients, and transplant recipients, providing crucial data for understanding long-term immunity patterns.
Specialized investigation of COVID-19 immunity in kidney and lung transplant patients, focusing on their unique immune responses and vulnerability to viral infections.
The research aims to enhance understanding of immune system functionality in transplant recipients during the ongoing pandemic.
Comprehensive monitoring of neutralizing antibodies against emerging viral variants, with particular attention to vulnerable populations in Belgium.
This multi-center study contributes to understanding the evolution of viral immunity across different patient groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
